Transaction #10865 · Form 4 · 0001213900-25-113114
Starling Oncology, Inc. · Other acquisition · Common Stock
Starling Oncology, Inc. · Transacted November 18, 2025 · Filed November 20, 2025
What does this filing report?
An SEC Form 4 filing for Starling Oncology, Inc. records an other acquisition involving Common Stock on November 18, 2025. The reported quantity was 141,149. The filing date is November 20, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Starling Oncology, Inc.
- Company CIK
- 0001799191
- Security type
- Non-derivative
- Acquisition type
- Other acquisition · Code J
- Quantity acquired
- 141,149
- Reported price
- Not reported · See footnotes
- Reference value
- Not reported
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 250,206
- Ownership description
- Not reported
- SEC acceptance time
- Nov 20, 2025, 4:02 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Ling Gabriel ↗
Director
CIK 0001945281
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- Consists of shares of common stock of the Issuer received by the reporting person through an in-kind distribution by M33 Growth I, L.P. to its limited partners and on a pro rata basis in accordance with their pecuniary interests therein in reliance on Rules 16a-9 and 16a-13 under the Securities Exchange Act of 1934, as amended.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.